Skip to content
DIVINHEALSimplifying Global Wellbeing
HOME
TREATMENTS
HOSPITALS
Hospital background

Preimplantation Genetic Testing (PGT) Success Rate in Haryana

Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.

Plan My Journey

Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway

Cost calculator

I know my treatment - show me cost from 3 hospitals

5K+ International Patients Treated

40+ Source Countries Served

500+ Accredited Partner Hospitals

98% Patient Satisfaction

80% Average Savings vs USA

10K+ Doctors

NABH, JCI Accredited Hospitals

Free Treatment Plan

Free Consultation with Doctor

5+ Destinations Covered

Dr Indu Priya

Written by DivinHeal Editorial Contributor, Rahul Kumar, Embryologist | Medically Reviewed by Dr Indu Priya, Gynecologist(MD) Published on: February 19, 2026

About

Preimplantation Genetic Testing (PGT) Success Rates in Haryana

Understanding the Preimplantation Genetic Testing (PGT) success rate in Haryana is crucial for individuals considering this advanced reproductive technology. Outcomes vary significantly based on the specific PGT type, underlying genetic factors, and individual patient profiles. This page details general trends observed across various clinical settings in the region, offering a clear perspective on expected results.

PGT success and Preimplantation Genetic Testing (PGT) survival rate in Haryana are rigorously reviewed through aggregated clinical data, aligning with national and international benchmarks. Evaluations consider multiple treatment parameters, patient demographics, and laboratory expertise. It is essential to recognize that individual results can differ, influenced by a unique combination of biological and procedural elements.

Defining Success in Preimplantation Genetic Testing (PGT)

For PGT, "success" encompasses several key milestones, including successful embryo biopsy, accurate genetic diagnosis, and the transfer of a euploid (genetically normal) embryo. Ultimately, it refers to the successful implantation leading to a viable pregnancy and a live birth. Short-term success focuses on diagnostic accuracy, while long-term success measures a healthy pregnancy outcome following embryo transfer.

Preimplantation Genetic Testing (PGT) Outcome Breakdown

Success rates vary depending on treatment approach and patient factors.

Treatment Type / Category Typical Use Case Success Rate Consideration What Success Indicates
PGT for Aneuploidy (PGT-A) Screening embryos for chromosomal abnormalities in IVF cycles. High diagnostic accuracy, varying live birth rates per transfer. Identification of euploid embryos for transfer, leading to higher implantation and live birth chances.
PGT for Monogenic Disorders (PGT-M) Identifying specific single-gene disorders (e.g., cystic fibrosis, Huntington's) in embryos. High accuracy in detecting specific genetic mutations, varied live birth rates. Transfer of unaffected embryos, significantly reducing the risk of transmitting the genetic condition.
PGT for Structural Rearrangements (PGT-SR) Detecting chromosomal structural abnormalities (e.g., translocations, inversions) in embryos. Reliable identification of balanced/normal embryos, live birth outcomes depend on severity. Selection of embryos free from parental structural rearrangements, improving pregnancy outcomes.

Preimplantation Genetic Testing (PGT) Survival Rate by Age in Haryana

The efficacy of PGT and subsequent outcomes are significantly influenced by maternal age, reflecting overall egg quality and embryo health. These age-related trends align with internationally observed clinical patterns, where older maternal age is associated with a higher incidence of aneuploidy.

Age Group (Maternal) Impact on PGT Outcomes Associated Success Trends
Under 35 Years Higher number of euploid embryos, better implantation potential. Generally higher rates of successful euploid embryo transfer and live birth.
35-39 Years Increased incidence of aneuploidy, reduced euploid embryo yield. Moderate success rates; PGT helps optimize outcomes by selecting viable embryos.
40-42 Years Significantly higher rates of chromosomal abnormalities. Lower overall euploid embryo rates, but PGT remains beneficial for selection.
Over 42 Years Very high aneuploidy rates, fewer embryos suitable for transfer. Challenges remain, though PGT can still identify rare euploid embryos for transfer.

Haryana vs. Global Preimplantation Genetic Testing (PGT) Outcomes

Success rates for Preimplantation Genetic Testing (PGT) in Haryana are comparable with international standards when similar protocols, technology, and patient selection are applied. Advanced fertility centers in Haryana maintain high standards, contributing to outcomes that reflect global benchmarks.

Region/Country PGT Live Birth Rate Trends
Haryana, India Outcomes show favorable trends, especially in specialized centers adhering to global best practices.
United States Reported rates are generally high, reflecting extensive research and technological adoption.
United Kingdom Consistent outcomes, supported by robust regulatory frameworks and clinical guidelines.
Australia Strong performance, with a focus on comprehensive patient care and advanced lab techniques.
Canada Positive outcomes, influenced by regulated healthcare systems and skilled specialists.
Spain Known for high IVF success, PGT outcomes are also competitive due to advanced clinics.
Germany Solid success rates, driven by stringent quality controls and technological integration.

Success rates are indicative, not guaranteed, and vary significantly depending on individual patient conditions and specific treatment approaches. These figures provide a general context of outcomes.

Factors Influencing PGT Success Rate and Preimplantation Genetic Testing (PGT) Recovery Rate in Haryana

  • Maternal Age: A primary factor influencing egg quality and the likelihood of euploid embryos.
  • Embryo Quality: Morphology and developmental stage of embryos selected for biopsy.
  • Underlying Genetic Condition: The specific genetic anomaly being screened can influence diagnostic complexity.
  • Laboratory Expertise: Skill and experience of embryologists performing biopsy and genetic analysis.
  • Clinic Experience: The overall proficiency of the fertility clinic in managing IVF and PGT cycles.
  • Female Fertility Factors: Other contributing factors like ovarian reserve and uterine health.
  • Male Fertility Factors: Sperm quality can also influence embryo development and genetic integrity.

Data Sources & Methodology

  • National and Regional Fertility Registries: Aggregated anonymized data from clinics across Haryana and India.
  • Peer-Reviewed Medical Literature: Studies published in reputable scientific journals on PGT outcomes.
  • International Reproductive Technology Organizations: Data and guidelines from global bodies like ESHRE and ASRM.
  • Multi-Hospital Outcome Data: Consolidated statistics from leading fertility centers regarding PGT efficacy.

Informed Choices for PGT

Making confident healthcare decisions requires access to clear, evidence-based information. Understanding PGT outcomes, including stage wise Preimplantation Genetic Testing (PGT) survival rate in Haryana, empowers individuals to pursue their family-building goals knowledgeably.

Hospitals

NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.

View All
Doctors

Meet Our Medical Specialists

View All
Aditi Dixit

Sr. Consultant – Women Imaging

Aditi Dixit

MBBS, MD

Haryana

Amit Jassal

Sr. Consultant - Anaesthesia

Amit Jassal

MBBS, MD

Haryana

Anjana Kharbanda

Sr. Consultant - Emergency

Anjana Kharbanda

MBBS, MD

India

Dr. Abhinandan Mukhopadhyay

Sr. Consultant - Urology & Kidney Transplant Program (Unit I)

Dr. Abhinandan Mukhopadhyay

MBBS, MD

India

Dr. Ajit Singh Baghela

Consultant

Dr. Ajit Singh Baghela

MBBS, MD

Gurugram

Aditi Dixit

Sr. Consultant – Women Imaging

Aditi Dixit

MBBS, MD

Haryana

Amit Jassal

Sr. Consultant - Anaesthesia

Amit Jassal

MBBS, MD

Haryana

Anjana Kharbanda

Sr. Consultant - Emergency

Anjana Kharbanda

MBBS, MD

India

Dr. Abhinandan Mukhopadhyay

Sr. Consultant - Urology & Kidney Transplant Program (Unit I)

Dr. Abhinandan Mukhopadhyay

MBBS, MD

India

Dr. Ajit Singh Baghela

Consultant

Dr. Ajit Singh Baghela

MBBS, MD

Gurugram

How DivinHeal Helps

We simplify your medical journey by providing comprehensive support and access to world-class healthcare.

Expert Specialist Matching

Connecting you with the world's top-rated medical experts.

FAQ

Everything you
need to know today

Browse through these common inquiries to better understand our patient-focused medical platform.

Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.

Yes, we provide secure online consultations with experienced specialists.

Our care coordinators help match you with the most suitable specialist.

Absolutely. Your medical information is protected according to healthcare privacy standards.

Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.

JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.

Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.

Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.

DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.

You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.

Still have more questions?

Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.